Encompass Health Corp (NYSE:EHC) Expected to Announce Earnings of $0.97 Per Share

Brokerages expect Encompass Health Corp (NYSE:EHC) to report $0.97 earnings per share (EPS) for the current quarter, according to Zacks. Seven analysts have provided estimates for Encompass Health’s earnings. The lowest EPS estimate is $0.95 and the highest is $1.00. Encompass Health posted earnings of $0.99 per share during the same quarter last year, which suggests a negative year-over-year growth rate of 2%. The business is expected to issue its next earnings report after the market closes on Monday, July 29th.

According to Zacks, analysts expect that Encompass Health will report full-year earnings of $3.80 per share for the current fiscal year, with EPS estimates ranging from $3.75 to $3.88. For the next fiscal year, analysts expect that the firm will post earnings of $3.84 per share, with EPS estimates ranging from $3.57 to $4.00. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research analysts that follow Encompass Health.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, April 25th. The company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.15. Encompass Health had a net margin of 7.14% and a return on equity of 23.82%. The business had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.11 billion.

A number of research analysts have recently commented on EHC shares. Barclays raised shares of Encompass Health from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $68.00 to $70.00 in a research report on Thursday, May 30th. BMO Capital Markets started coverage on shares of Encompass Health in a research report on Thursday, June 27th. They issued an “outperform” rating and a $72.00 price objective for the company. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $78.00.

EHC stock traded up $0.11 during midday trading on Friday, hitting $65.51. The company’s stock had a trading volume of 928,975 shares, compared to its average volume of 683,841. The company has a quick ratio of 0.89, a current ratio of 0.89 and a debt-to-equity ratio of 1.71. Encompass Health has a twelve month low of $56.74 and a twelve month high of $82.46. The business has a fifty day moving average price of $62.01. The firm has a market cap of $6.48 billion, a PE ratio of 18.05, a P/E/G ratio of 2.20 and a beta of 0.81.

The company also recently disclosed a quarterly dividend, which was paid on Monday, July 15th. Stockholders of record on Monday, July 1st were given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date was Friday, June 28th. Encompass Health’s dividend payout ratio (DPR) is presently 29.75%.

About Encompass Health

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Featured Article: Special Dividends

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.